Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. D. Gamble
P53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
Cancer Research
Cancer Research
Oncology
Related publications
Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma
Cancer Research
Cancer Research
Oncology
Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma
Oncotarget
Oncology
ABCC4/MRP4: A MYCN-regulated Transporter and Potential Therapeutic Target in Neuroblastoma
Frontiers in Oncology
Cancer Research
Oncology
PRIMA-1MET-induced Neuroblastoma Cell Death Is Modulated by P53 and Mycn Through Glutathione Level
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
D133p53 Isoform Is a Direct P53 Target Gene That Modulates P53 Tumour Suppressor Activity
Breast Cancer Research
Cancer Research
Oncology
Ribosomal Protein S27L Is a Direct P53 Target That Regulates Apoptosis
Oncogene
Cancer Research
Genetics
Molecular Biology
Phox2B Correlates With MYCN and Is a Prognostic Marker for Neuroblastoma Development
Oncology Letters
Cancer Research
Oncology
Long Non-Coding RNA NEAT1 Is a Transcriptional Target of P53 and Modulates P53-Induced Transactivation and Tumor-Suppressor Function
International Journal of Cancer
Cancer Research
Oncology
Glutathione Biosynthesis Is Upregulated at the Initiation of MYCN-driven Neuroblastoma Tumorigenesis
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine